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Background: Although the number of reporting guidelines has grown rapidly, few have gone through an updating
process. The STARD statement (Standards for Reporting Diagnostic Accuracy), published in 2003 to help improve the
transparency and completeness of reporting of diagnostic accuracy studies, was recently updated in a systematic way.
Here, we describe the steps taken and a justification for the changes made.
Results: A 4-member Project Team coordinated the updating process; a 14-member Steering Committee was
regularly solicited by the Project Team when making critical decisions. First, a review of the literature was
performed to identify topics and items potentially relevant to the STARD updating process. After this, the 85
members of the STARD Group were invited to participate in two online surveys to identify items that needed
to be modified, removed from, or added to the STARD checklist. Based on the results of the literature review
process, 33 items were presented to the STARD Group in the online survey: 25 original items and 8 new
items; 73 STARD Group members (86 %) completed the first survey, and 79 STARD Group members (93 %)
completed the second survey.Then, an in-person consensus meeting was organized among the members of
the Project Team and Steering Committee to develop a consensual draft version of STARD 2015. This version
was piloted in three rounds among a total of 32 expert and non-expert users. Piloting mostly led to
rewording of items. After this, the update was finalized. The updated STARD 2015 list now consists of 30
items. Compared to the previous version of STARD, three original items were each converted into two new
items, four original items were incorporated into other items, and seven new items were added.
Conclusions: After a systematic updating process, STARD 2015 provides an updated list of 30 essential items
for reporting diagnostic accuracy studies.
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The STARD statement (Standards for Reporting Diag-
nostic Accuracy) was published in 2003. It was intended
to help improve the transparency and completeness of
reporting of diagnostic accuracy studies. STARD pre-
sented a checklist of 25 items that authors should ad-
dress when reporting diagnostic accuracy studies [1, 2].
Since its publication, STARD has been adopted by
more than 200 biomedical journals [3]. Evaluations of
adherence to STARD have revealed statistically signifi-
cant but modest improvements over time in the report-
ing of diagnostic accuracy studies [4–6]. Unfortunately,
reporting remains inadequate for many studies, and
journals differ in the extent to which they endorse
STARD, recommend it to authors, and use it in the edi-
torial and peer-review process [7–10].
STARD had not been updated in the first 10 years of
its existence. In February 2013, the STARD Steering
Committee agreed that an update was justified to
achieve two main goals (1) to include new items, based
on improved understanding of sources of bias and vari-
ability, and (2) to facilitate the use of the list, by rearran-
ging and rephrasing existing items, and by improving
consistency in wording with other major reporting
guidelines such as CONSORT (Consolidated Standards
of Reporting Trials) [11].
Although the number of reporting guidelines has
grown rapidly, few have gone through an updating
process [12]. In this paper, we describe the steps taken
to update the original STARD statement, resulting in
STARD 2015 [13], and provide a justification for the
changes made. The description of our methods may
serve as guidance for other groups considering updates
of their reporting guidelines.
Methods
Figure 1 summarizes our approach for updating STARD
and lists critical milestones.
Participants in the development of STARD 2015
The following groups of participants, detailed in Additional
file 1, were involved in the STARD updating process.
Project Team
A four-member STARD 2015 Project Team was estab-
lished, which was responsible for coordinating the up-
dating process. This team secured funding, identified
and invited potential new members of the STARD
Group, reviewed the literature, conducted and analyzed
web-based surveys, organized an in-person consensus
meeting, drafted the items and accompanying docu-
ments, and coordinated piloting of the resulting
STARD 2015 list.Steering Committee
A 14-member STARD 2015 Steering Committee was also
established, which was responsible for providing the Pro-
ject Team with specific guidance throughout the updating
process. This committee consisted of all ten members of
the STARD 2003 Steering Committee [14], along with
three journal editors from Clinical Chemistry, JAMA, and
Radiology, and the founder of the EQUATOR Network
(Enhancing the Quality and Transparency of Health
Research), an umbrella organization that promotes
complete and transparent reporting [15].STARD Group
All 30 members of the original STARD 2003 Group
were invited to contribute to the updating process
and to suggest potential new members. Other poten-
tial new STARD Group members were identified from
STARD-related publications during discussions within
the Project Team. The resulting STARD 2015 Group
now has 85 members; it consists of researchers, jour-
nal editors, healthcare professionals, methodologists, a
science journalist, statisticians, other stakeholders, and
the members of the Project Team and Steering Com-
mittee. STARD Group members were invited to
participate in two web-based surveys to help identify
essential items for reporting diagnostic accuracy
studies.Review of the literature
In January and February 2014, the Project Team under-
took a review of the literature to identify items that
could be modified, added to, or removed from the
original STARD checklist. This literature search focused
on eight areas, which are detailed in Additional file 2.
In short, we searched MEDLINE (through PubMed)
and the Cochrane Methodology Register, supplemented
by non-systematic searches, for topics and items poten-
tially relevant to the STARD updating process in three
categories: (1) general considerations about diagnostic
accuracy studies and reporting, (2) evidence and state-
ments suggesting modifications to the original STARD
checklist or flow diagram, and (3) evidence and state-
ments suggesting new STARD items.
Titles and abstracts were screened by one of two
reviewers (DAK or JFC), and potentially eligible publica-
tions were retrieved for full-text assessment, again by
one of these two reviewers. The electronic search results
were augmented by the personal article collections of
the Project Team. Based on the results of this search,
the Project Team decided which items should be pre-
sented for consideration to the STARD Group in an on-
line survey.
Fig. 1 Milestones in the development of STARD 2015
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General structure
We used two web-based surveys to help decide on items
that needed to be modified, added to, or removed from
the STARD checklist [12]. The surveys were developed
by the Project Team in SurveyMonkey© and informally
piloted in their institution prior to distribution.
All 85 members of the STARD Group were invited by
email to participate in each survey. Near the closing
dates, non-responders were sent two reminders, 1 week
apart.
Participant responses were summarized by the Project
Team and reported back to participants at the end of
each survey. The Project Team and Steering Committee
had a teleconference in May 2014 to discuss the results
of the first survey and to decide on the outline of the
second survey. They also set priorities for topics to dis-
cuss during the in-person consensus meeting.
First survey
A link to the first survey was sent to the STARD Group on
April 16, 2014; the survey was closed on May 31, 2014. The
questionnaire consisted of two parts, each containing a set
of multiple-choice questions and is provided in Additional
file 3.
In the first part of the questionnaire, participants were
asked to comment on each of the 25 original STARD
items, in order of their appearance in the original check-
list. For each item, participants were invited to indicate
whether they would prefer to keep the item as it is, to
modify the item, or remove the item from the checklist.
Each question was accompanied by a suggestion from
the Project Team, supported by a brief rationale, based
on the literature search results. Each question also con-
tained an open-comment box in which participants
could clarify their responses.
In the second part of the questionnaire, participants
were asked whether or not they felt that proposed po-
tential new items should be added to the list. The ques-
tionnaire also addressed general considerations about
the scope of STARD and preferred wording and a box
for further suggestions.
Second survey
A link to the second survey was distributed to the
STARD Group on July 16, 2014; this survey closed on
August 30, 2014. The invitation letter contained a docu-
ment that summarized the results of the first survey.
The questionnaire is provided in Additional file 4.
This second survey focused on items for which less than
75 % of the responders agreed on one of the multiple
choice options in the first survey. Response options that
had been selected by less than 20 % of the respondents in
the first survey were removed from the questionnaire.Based on the open comments provided by the respon-
dents in the first survey, a brief summary of the main ar-
guments for and against each proposed modification was
presented for each item.
Results from the second survey were summarized by
the Project Team and used to prepare the first draft
version of STARD 2015. Items for which there was no
majority response were considered high-priority topics
for discussion during the in-person consensus meeting.In-person consensus meeting
The 14 members from the STARD 2015 Steering Com-
mittee were invited to a 2-day consensus meeting, held
in Amsterdam, The Netherlands, on September 27–28,
2014. The meeting was organized, coordinated, and
chaired by the Project Team. The primary objective was
to develop a consensual draft version of STARD 2015.
Secondary objectives were to discuss dissemination and
implementation plans for STARD 2015 and additional
initiatives around STARD and to discuss how STARD
2015 could be integrated into long-term development
strategies of the EQUATOR network [15].
After the meeting, Project Team members further re-
vised the consensual draft version of STARD 2015, with
collected comments and suggestions, and modified the
prototype flow diagram that was provided in the original
STARD statement. The updated consensual draft version
was circulated by email to the STARD Group for feed-
back. The Project Team collected comments and sugges-
tions and modified the list accordingly.Piloting STARD 2015
Three rounds of piloting among expert and non-expert
users of STARD were organized. The main aim of these
piloting sessions was to identify items on the consensual
draft version of STARD 2015 that were vague, ambigu-
ous, difficult to interpret, or missing.Piloting among radiology residents
STARD 2015 was piloted among radiology residents from
the Department of Radiology, Academic Medical Center,
University of Amsterdam, The Netherlands. Residents
were invited through email to read a diagnostic accuracy
study report [16] and to use the checklist to evaluate com-
pleteness of reporting. This was followed by a focus group
meeting, which took place on December 15, 2014. During
a 90-min conversation, the moderator (DAK) invited the
participants to comment on the wording and on the lay-
out of the list. Thereafter, participants were invited to
share how they had evaluated each item in the article pro-
vided and their experience with using the checklist.
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The editor-in-chief of Radiology invited editorial board
members and reviewers of diagnostic accuracy studies to
pilot the consensual draft version of STARD 2015 and to
provide comments using an online questionnaire devel-
oped by the Project Team (Additional file 5). Responses
were collected in SurveyMonkey© between January 9
and April 1, 2015. Invitees were asked to answer eight
“yes/no/no opinion” questions about the list, with the
option to clarify answers in an open-comment box. Spe-
cifically, they were asked whether the aim of STARD
2015 was clear; whether terminology, layout, and outline
used were appropriate; and whether any item or infor-
mation was particularly difficult to understand or
missing.
Piloting among laboratory medicine experts
The editor-in-chief of Clinical Chemistry invited editors
and reviewers of the journal to evaluate the consensual
draft version of STARD 2015. Responses were collected
between February 26 and March 9, 2015. Collaborators
were asked to review the list and to provide feedback on
whether they found the language understandable and
the items sufficiently clear. They were also asked to indi-
cate if any information deemed essential in evaluating la-
boratory medicine diagnostic accuracy studies was
currently not addressed. This was done by email.
Finalizing STARD 2015
The consensual draft version of the STARD 2015 list
was updated following the piloting sessions. The Project
Team summarized the feedback obtained from piloting
and shared the results with the Steering Committee. In a
teleconference on May 7, 2015, the Project Team and
the Steering Committee decided on the final STARD
2015 list of essential items.
Initial strategies for disseminating STARD 2015
In August 2015, we non-systematically searched PubMed
for editorials and news items that had been published
about STARD since its launch in 2003, and 33 were identi-
fied, published in 28 different journals. One author (JFC)
collected the email addresses of the editors-in-chief or the
editorial offices of these publishing journals. On November
26, 2015, these were contacted to inform them about the
STARD 2015 update and to invite them to write an editor-
ial or commentary around it.
In August 2015, we also searched PubMed for diag-
nostic accuracy studies that had been published between
January and December 2014, using the following strat-
egy: (sensitivity[tw] AND specificity[tw]) OR diagnostic
accuracy[tw] OR predictive value*[tw] OR likelihood
ratio*[tw] OR AUC[tw] OR ROC[tw]). We then ordered
the search results by journal and established a list of the100 journals that published most studies. For these jour-
nals, one author (DAK) collected the email addresses of
the editors-in-chief or the editorial offices, and these
were contacted on February 4, 2016, to inform them
about the STARD 2015 update, and with the request to
consider using and endorsing it.
Results
Review of the literature
A total of 113 full-text articles and reports were
reviewed in preparation for the STARD 2015 update. A
summary of the results of the literature review is
provided in Additional file 6.
Based on the results of this review process, the Project
Team decided to present 33 items—the 25 original items
and 8 new items—for consideration to the STARD
Group in the online survey. These eight potential new
items were (1) positivity cutoffs for continuous tests
when reporting area under the receiver operating char-
acteristic curve, (2) sample size calculation, (3) trial
registration number, (4) link to online resources, (5)
availability of the study protocol, (6) data sharing policy,
(7) conflicts of interest, and (8) sources of funding.
Online survey
First survey
Seventy-three STARD Group members (86 %) com-
pleted the first survey. Detailed survey results are pro-
vided in Additional file 7. For the 25 items in the
original STARD checklist, more than three quarters of
respondents agreed to keep five items as they were (ori-
ginal STARD items 5/10/17/18/21) and to modify 13
items (original STARD items 2/4/6/8/9/11/12/13/14/16/
19/22/24). There was less than 75 % agreement on the
seven other items (original STARD items 1/3/7/15/20/
23/25). Of the eight potential new items proposed, more
than 75 % of respondents voted in favor of including
four: sample-size calculation, availability of the study
protocol, conflicts of interest, and sources of funding.
Second survey
Seventy-nine STARD Group members (93 %) completed
the second survey. Detailed survey results are provided
in Additional file 7. The survey addressed eight
remaining questions: six items on the original STARD
checklist for which less than 75 % of respondents indi-
cated the same answer in the first survey (original
STARD items 3/7/15/20/23/25), one potential new item
(positivity cutoffs for continuous tests when reporting
area under the receiver operating characteristic curve),
and one wording issue (continuing to use the term
“diagnostic accuracy” rather than moving to “diagnostic
performance” as the key concept in reporting compari-
sons of medical tests with a clinical reference standard).
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unchanged and to modify item 23 as suggested by the
Project Team. No majority response was obtained for
the other six questions.In-person consensus meeting
The Project Team and all but 3 of the 14 members of
the Steering Committee attended the in-person consen-
sus meeting (Additional file 1). On the first day, the
items in the draft version of STARD 2015 and items for
which no 75 % majority response were reached in the
survey were discussed until consensus was reached on
inclusion and phrasing. Thereafter, discussions focused
on dissemination and uptake by journals, research insti-
tutions and authors, and strategies for piloting the list. It
was also decided that a subgroup should develop a one-
page explanatory document that briefly describes the
aims of STARD 2015 and the key concepts in it to ac-
company the 2015 version when distributed.
On the second day, further discussions focused on
finalizing a consensual draft version of STARD 2015.
After this, additional initiatives around STARD were dis-
cussed. The meeting participants agreed that it would be
valuable to develop extensions of STARD with more
specific guidance for reporting diagnostic accuracy stud-
ies in different research fields (e.g., laboratory medicine
and radiology) and applications of STARD for specific
forms of testing (e.g., physical examination) or specific
target conditions (e.g., dementia). The group agreed that
STARD should also develop guidance for writing ab-
stracts of diagnostic accuracy studies (STARD for Ab-
stracts; in progress) and for registering protocols of
diagnostic accuracy studies in trial registries (STARD for
Registration; in progress).Piloting STARD 2015
Piloting among radiology residents
Four radiology residents (three men, one woman; age
range 25–35 years; two of them with a PhD) participated
in the initial piloting. Three of them declared being
aware of the existence of STARD; two had previously
used STARD for the critical appraisal of a diagnostic ac-
curacy report they had to present during weekly journal
clubs at the Department of Radiology. Comments of the
participants were collected. From the interviews, we
concluded that a majority of items on the consensual
draft version of STARD 2015 were relevant and under-
standable by non-expert users. Residents suggested
minor rewording for some items, adding explanation of
key terms (such as “target condition” and “intended use
of a test”), and a pointer to STARD for Abstracts cur-
rently in development.Piloting among radiology experts
Twenty editorial board members and peer reviewers from
Radiology completed the online piloting survey. Seventeen
respondents were clinical radiologists, 2 were journal edi-
tors, and 1 was a biomedical researcher. All but one
respondent declared having previously (co-)authored a
diagnostic accuracy study. Detailed results are provided in
Additional file 8. Most respondents considered the con-
sensual draft version of the STARD 2015 list of essential
items and accompanying one-page explanatory document
as understandable and complete.Piloting among laboratory medicine experts
Eight experts in the field of laboratory medicine pro-
vided feedback on the consensual draft version of
STARD 2015 and the one-page explanation. Three ex-
perts indicated that the current draft version may not
cover important elements of laboratory test evaluations,
such as reproducibility of tests and collection, handling,
and storage of samples. These experts highlighted the
need for specific extensions or complementary docu-
ments dedicated to laboratory tests. Some respondents
also suggested minor modifications and edits to the list.Finalizing STARD 2015
Amended draft versions of STARD 2015 were prepared.
Based on the feedback provided during piloting, a new
item pointing to STARD for Abstracts was added to the
checklist, and a table to clarify key STARD terminology
was developed [13]. Additional changes at this stage
consisted mostly of minor wording modifications. On
May 7, 2015, the Project Team and Steering Committee
met in a teleconference during which the results from
the piloting sessions were discussed, and STARD 2015
was finalized (Table 1) [13].
STARD 2015 consists of 30 items, with 4 items having
an (a) and (b) part. A detailed rationale for modifying or
adding items is provided in Additional file 9, with a
summary of the main changes in Table 2. Compared to
the original STARD checklist, three original items were
each converted into two new items, four original items
were incorporated into other items and seven completely
new items were added. A modified prototype flow dia-
gram, to illustrate the flow of participants through the
study, was incorporated (Fig. 2). The remaining items
were reworded to make them easier to understand or to
bring them in line with phrasing used in other major
reporting guidelines, such as CONSORT. [11] STARD
2015 now also has an accompanying one-page explana-
tory document that can be distributed along with it
(Additional file 10). An updated “Explanation and Elab-
oration” document, which explains each item in detail
and gives examples of good reporting [2], is under
Table 1 The STARD 2015 list
Section and topic No. Item
Title or abstract
1 Identification as a study of diagnostic accuracy using at least one measure
of accuracy (such as sensitivity, specificity, predictive values, or AUC)
Abstract
2 Structured summary of study design, methods, results, and conclusions
(for specific guidance, see STARD for Abstracts)
Introduction
3 Scientific and clinical background, including the intended use and clinical
role of the index test
4 Study objectives and hypotheses
Methods
Study design 5 Whether data collection was planned before the index test and reference
standard were performed (prospective study) or after (retrospective study)
Participants 6 Eligibility criteria
7 On what basis potentially eligible participants were identified (such as
symptoms, results from previous tests, inclusion in registry)
8 Where and when potentially eligible participants were identified (setting,
location, and dates)
9 Whether participants formed a consecutive, random, or convenience series
Test methods 10a Index test, in sufficient detail to allow replication
10b Reference standard, in sufficient detail to allow replication
11 Rationale for choosing the reference standard (if alternatives exist)
12a Definition of and rationale for test positivity cutoffs or result categories of
the index test, distinguishing pre-specified from exploratory
12b Definition of and rationale for test positivity cutoffs or result categories of
the reference standard, distinguishing pre-specified from exploratory
13a Whether clinical information and reference standard results were available
to the performers or readers of the index test
13b Whether clinical information and index test results were available to the
assessors of the reference standard
Analysis 14 Methods for estimating or comparing measures of diagnostic accuracy
15 How indeterminate index test or reference standard results were handled
16 How missing data on the index test and reference standard were handled
17 Any analyses of variability in diagnostic accuracy, distinguishing pre-specified
from exploratory
18 Intended sample size and how it was determined
Results
Participants 19 Flow of participants, using a diagram
20 Baseline demographic and clinical characteristics of participants
21a Distribution of severity of disease in those with the target condition
21b Distribution of alternative diagnoses in those without the target condition
22 Time interval and any clinical interventions between index test and
reference standard
Test results 23 Cross tabulation of the index test results (or their distribution) by the results
of the reference standard
24 Estimates of diagnostic accuracy and their precision (such as 95 %
confidence intervals)
25 Any adverse events from performing the index test or the reference standard
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Table 1 The STARD 2015 list (Continued)
Discussion
26 Study limitations, including sources of potential bias, statistical uncertainty,
and generalizability
27 Implications for practice, including the intended use and clinical
role of the index test
Other information
28 Registration number and name of registry
29 Where the full study protocol can be accessed
30 Sources of funding and other support; role of funders
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publication.
The STARD 2015 list and the explanatory document
have been released under a Creative Commons license
that allows for redistribution, commercial and non-
commercial use, as long as it is passed along unchanged
and in whole, with credit to the STARD Group. All
STARD-related material will be made accessible through
the EQUATOR website upon completion (www.equator-
network.org/reporting-guidelines/stard/).
Discussion
Having completed the update of STARD, we would like to
share a few observations and reflections. These can be read
as limitations that we acknowledge, encouragement for
others who are considering an update or an extension of a
reporting guideline, and background information for users
of reporting guidelines, such as STARD.
Even though STARD intends to cover reports of all
studies that provide estimates of a test’s diagnostic accur-
acy, it may not be adequate to serve the special needs of
each field. For specific types of tests and specific applica-
tions of testing, readers may wish to have more informa-
tion to help them interpret and appreciate the study
findings. The STARD Group encourages the development















A detailed overview of the changes made in STARD 2015, and the rationale for thesfields of diagnostic research, and development of STARD
applications, explaining how the STARD items should be
operationalized for specific forms of testing or target con-
ditions [17, 18]. Such extensions should not replace the
whole of STARD, but rather modify or extend individual
items, or possibly just interpret the items in a particular
context. More details on how to develop extensions have
been reported elsewhere [13].
Based on the accumulated experience since the devel-
opment of STARD in 2003, we now firmly believe that
developing a reporting checklist is in itself not sufficient
to improve reporting [19]. We now see STARD 2015 as
a list of essential items that provides a basis from which
additional instruments have to be developed to address
the needs of particular audiences. Though based on the
STARD 2015 items, these instruments may differ, as they
will target different potential users: not only authors of
completed studies but also peer reviewers, journal edi-
tors, authors of conference abstracts, authors of study
protocols, maybe even readers. Such instruments could,
for example, be specific templates with standard text for
authors, to facilitate complete reporting, or prototype
statements for peer reviewers, who can point to report-
ing failures and explain why they need to be addressed.
A writing aid for authors has been shown to be benefi-
cial for improving reporting of randomized trials [20].ors are invited to..
rt a structured abstract, according to STARD for Abstracts (item 2).
rt the intended use and clinical role of the index test under
stigations (item 3), along with specific study hypotheses (item 4).
rt whether test positivity cutoffs or result categories were pre-specified
xploratory (item 12), whether analyses of variability in diagnostic accuracy
pre-specified or exploratory (item 17), and how they determined the
ded sample size (item 18).
ys provide a diagram, illustrating the flow of participants through the
y (item 19).
ss potential study limitations (item 26) and the implications for practice
e study findings (item 27).
rt the registration number (item 28), where the full study protocol can
ccessed (item 29), and sources of funding (item 30).
e changes, is provided in Additional file 9
Fig. 2 Prototypical STARD diagram to report flow of participants through the study
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2015 items are guidance for reporting journal and con-
ference abstracts and for registration of protocols of
diagnostic accuracy studies in trial registries, initiatives
that are currently ongoing.
Most reporting guidelines have not undergone user
testing prior to their release, which may be surprising,
given that reporting guidelines are primarily tools de-
signed to help others, and they should be evaluated as
such. We therefore decided to pilot STARD 2015 among
different groups of potential users. This piloting was still
relatively modest, but it helped us to improve the list in
several key respects, especially in terms of wording.
Although we substantially extended membership of
the STARD Group, the STARD 2015 update process
mostly included experienced researchers and authors,
and most of them were from USA, UK, or The
Netherlands. To judge the formulation and user friendli-
ness of items, the opinion of future users is important as
well. The selection of items should be based on strong
evidence and sound principles but the development of
actual tools and instruments should be guided by re-
peated, targeted, and methodical user testing.
Conclusion
After a systematic updating process, STARD 2015 pro-
vides an updated list of 30 essential items for reporting
diagnostic accuracy studies. Incomplete reporting is now
considered to be one of the largest sources of avoidablewaste in biomedical research [21]. We believe that report-
ing can be substantially improved, with relatively little ef-
fort from multiple parties: from those responsible for
training researchers, from the authors themselves, from
journal editors, from peer reviewers, and from funders
[22]. We invite all stakeholders to help disseminate
STARD 2015 and to help the STARD Group in its efforts
to promote more complete, more transparent, and more
informative reporting of evaluations of medical tests.
Additional files
Additional file 1: The STARD 2015 Group. (DOCX 38 kb)
Additional file 2: Literature review: search strategy. (DOCX 35 kb)
Additional file 3: First online questionnaire. (PDF 502 kb)
Additional file 4: Second online questionnaire. (PDF 208 kb)
Additional file 5: Questionnaire for piloting among experts in the field
of imaging. (PDF 83 kb)
Additional file 6: Literature review: results. (DOCX 141 kb)
Additional file 7: Summary of responses to the online surveys.
(DOCX 31 kb)
Additional file 8: Feedback from editorial board members and reviewers
from Radiology. (DOCX 28 kb)
Additional file 9: Rationale for STARD 2015 items. (DOCX 45 kb)
Additional file 10: One-page explanation of STARD 2015. (DOCX 32 kb)
Abbreviations
CONSORT: Consolidated Standards of Reporting Trials; EQUATOR: Enhancing
the Quality and Transparency of Health Research; STARD: Standards for
Reporting Diagnostic Accuracy.
Korevaar et al. Research Integrity and Peer Review  (2016) 1:7 Page 10 of 10Acknowledgements
The authors thank Jeroen G. Lijmer, Drummond Rennie, Herbert Y. Kressel,
Nader Rifai, and Robert M. Golub who were also members of the STARD
2015 Steering committee.
Funding
There was no explicit funding for the development of STARD 2015. The
Academic Medical Center of the University of Amsterdam, The Netherlands,
partly funded the meeting of the STARD Steering Group but had no
influence on the development or dissemination of the list of essential items.
STARD Steering Group members and STARD Group members covered
additional personal costs individually.
Availability of data and materials
The data supporting the development of STARD are available in the
Additional files.
Authors’ contributions
DAK, JFC, LH, and PMMB designed the study. DAK, JFC, and PMMB prepared
the tables, figures, and appendices. DAK, JFC, and PMMB drafted the paper.
CAG, LH, JBR, DEB, PPG, LI, DM, HCWdV, and DGA critically revised the paper.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Clinical Epidemiology, Biostatistics and Bioinformatics,
Academic Medical Centre, University of Amsterdam, Amsterdam, The
Netherlands. 2INSERM UMR 1153 and Department of Pediatrics, Necker
Hospital, AP-HP, Paris Descartes University, Paris, France. 3Julius Center for
Health Sciences and Primary Care, University Medical Center Utrecht,
University of Utrecht, Utrecht, The Netherlands. 4Department of Pathology,
University of Virginia School of Medicine, Charlottesville, VA, USA. 5Center for
Statistical Sciences, Brown University School of Public Health, Providence, RI,
USA. 6Centre for Research in Evidence-Based Practice, Faculty of Health
Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia.
7Screening and Diagnostic Test Evaluation Program, School of Public Health,
University of Sydney, Sydney, New South Wales, Australia. 8Clinical
Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
9School of Epidemiology, Public Health and Preventive Medicine, University
of Ottawa, Ottawa, Canada. 10Department of Epidemiology and Biostatistics,
EMGO Institute for Health and Care Research, VU University Medical Center,
Amsterdam, The Netherlands. 11Centre for Statistics in Medicine, Nuffield
Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,
University of Oxford, Oxford, UK. 12Dutch Cochrane Centre, Julius Center for
Health Sciences and Primary Care, University Medical Center Utrecht,
University of Utrecht, Utrecht, The Netherlands.
Received: 6 February 2016 Accepted: 12 April 2016
References
1. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al.
Towards complete and accurate reporting of studies of diagnostic accuracy:
the STARD initiative. Ann Intern Med. 2003;138(1):40–4.
2. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al.
The STARD statement for reporting studies of diagnostic accuracy:
explanation and elaboration. Ann Intern Med. 2003;138(1):W1–W12.
3. Ochodo EA, Bossuyt PM. Reporting the accuracy of diagnostic tests: the
STARD initiative 10 years on. Clin Chem. 2013;59(6):917–9.
4. Korevaar DA, van Enst WA, Spijker R, Bossuyt PM, Hooft L. Reporting quality
of diagnostic accuracy studies: a systematic review and meta-analysis of
investigations on adherence to STARD. Evid Based Med. 2014;19(2):47–54.
5. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Reitsma JB,
Bossuyt PM, et al. Quality of reporting of diagnostic accuracy studies.
Radiology. 2005;235(2):347–53.
6. Korevaar DA, Wang J, van Enst WA, Leeflang MM, Hooft L, Smidt N, et al.
Reporting diagnostic accuracy studies: some improvements after 10 years of
STARD. Radiology. 2015;274(3):781–9.7. Hirst A, Altman DG. Are peer reviewers encouraged to use reporting
guidelines? A survey of 116 health research journals. PLoS One.
2012;7(4):e35621.
8. Kunath F, Grobe HR, Rucker G, Engehausen D, Antes G, Wullich B, et al. Do
journals publishing in the field of urology endorse reporting guidelines? A
survey of author instructions. Urol Int. 2012;88(1):54–9.
9. Knuppel H, Metz C, Meerpohl JJ, Strech D. How psychiatry journals support
the unbiased translation of clinical research. A cross-sectional study of
editorial policies. PLoS One. 2013;8(10):e75995.
10. Meerpohl JJ, Wolff RF, Niemeyer CM, Antes G, von Elm E. Editorial policies
of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc
Med. 2010;164(3):268–72.
11. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement:
updated guidelines for reporting parallel group randomised trials. PLoS
Med. 2010;7(3):e1000251.
12. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health
research reporting guidelines. PLoS Med. 2010;7(2):e1000217.
13. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al.
STARD 2015: an updated list of essential items for reporting diagnostic
accuracy studies. BMJ. 2015;351:h5527.
14. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al.
Towards complete and accurate reporting of studies of diagnostic accuracy:
the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin
Chem. 2003;49(1):1–6.
15. Altman DG, Simera I, Hoey J, Moher D, Schulz K. EQUATOR: reporting
guidelines for health research. Lancet. 2008;371(9619):1149–50.
16. Omoumi P, Bafort AC, Dubuc JE, Malghem J, Vande Berg BC, Lecouvet FE.
Evaluation of rotator cuff tendon tears: comparison of multidetector CT
arthrography and 1.5-T MR arthrography. Radiology. 2012;264(3):812–22.
17. Simel DL, Rennie D, Bossuyt PM. The STARD statement for reporting
diagnostic accuracy studies: application to the history and physical
examination. J Gen Intern Med. 2008;23(6):768–74.
18. Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum SJ, et al.
Reporting standards for studies of diagnostic test accuracy in dementia: The
STARDdem Initiative. Neurology. 2014;83(4):364–73.
19. Editors PM. From checklists to tools: lowering the barrier to better research
reporting. PLoS Med. 2015;12(11):e1001910.
20. Barnes C, Boutron I, Giraudeau B, Porcher R, Altman DG, Ravaud P.
Impact of an online writing aid tool for writing a randomized trial
report: the COBWEB (Consort-based WEB tool) randomized controlled
trial. BMC Med. 2015;13:221.
21. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al.
Reducing waste from incomplete or unusable reports of biomedical
research. Lancet. 2014;383(9913):267–76.
22. Moher D, Glasziou P, Chalmers I, Nasser M, Bossuyt PM, Korevaar DA,
Graham ID, Ravaud P, Boutron I. Increasing value and reducing waste in
biomedical research: who’s listening? Lancet. 2016;387(10027):1573–86.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
